carvedilol has been researched along with Muscle Weakness in 1 studies
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadoya, T | 1 |
| Sakakibara, A | 1 |
| Kitayama, K | 1 |
| Yamada, Y | 1 |
| Higuchi, S | 1 |
| Kawakita, R | 1 |
| Kawasaki, Y | 1 |
| Fujino, M | 1 |
| Murakami, Y | 1 |
| Shimura, M | 1 |
| Murayama, K | 1 |
| Ohtake, A | 1 |
| Okazaki, Y | 1 |
| Koga, Y | 1 |
| Yorifuji, T | 1 |
1 other study available for carvedilol and Muscle Weakness
| Article | Year |
|---|---|
Successful treatment of infantile-onset ACAD9-related cardiomyopathy with a combination of sodium pyruvate, beta-blocker, and coenzyme Q10.
Topics: Acidosis; Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenases; Adrenergic beta-Antagonists; Amino Acid M | 2019 |